SCHEMBL20205709

SCHEMBL20205709

CC1(C)c2cc3c(cc2-c2c1cc(-c1cc(-c4ccccc4)cc(-c4ccccc4)c1)c1c2oc2ccccc21)C(C)(C)c1cc(-c2cc(-c4ccccc4)cc(-c4ccccc4)c2)c2oc4ccccc4c2c1-3

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC14B O60729 1/20 0.33
▸ CDC14A Q9UNH5 1/20 0.33
▸ PGR P06401 1/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ MAPT P10636 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ CYP3A4 P08684 2/20 0.32
▸ HPGD P15428 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ ALPI P09923 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ PKM P14618 1/20 0.32
▸ CASP3 P42574 1/20 0.32
▸ RECQL P46063 1/20 0.32
▸ BLM P54132 1/20 0.32
▸ CASP7 P55210 1/20 0.32
▸ CASP6 P55212 1/20 0.32
▸ MCL1 Q07820 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20205319 0.96 CDC14B (0.34) CDC14BCDC14APGRMEN1MAPT
SCHEMBL20205379 0.95 CDC14B (0.35) CDC14BCDC14APGRMEN1MAPT
SCHEMBL20205323 0.94 PLA2G2A (0.34) CDC14BCDC14APGRMAPTHPGD
SCHEMBL20205741 0.94 CDC14B (0.36) CDC14BCDC14APGRMEN1MAPT
SCHEMBL20205320 0.94 CDC14B (0.37) CDC14BCDC14APGRMEN1MAPT
SCHEMBL23351760 0.92 PLA2G2A (0.33) CDC14BCDC14AMEN1MAPTKMT2A
SCHEMBL20205710 0.91 CDC14B (0.34) CDC14BCDC14AMEN1MAPTKMT2A
SCHEMBL20205309 0.91 PLA2G2A (0.36) CDC14BCDC14APGRMEN1MAPT
SCHEMBL20205313 0.90 CDC14B (0.38) CDC14BCDC14APGRMEN1MAPT
SCHEMBL20205307 0.90 CDC14B (0.39) CDC14BCDC14APGRMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) MERCK PATENT GMBH (DE) 2022-09-27 — — US disclosed
EP-3544985-B1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2021-05-12 — — EP disclosed
WO-2018095940-A1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2018-05-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) OCIAD2, OCIAD1, JUND CDC14B 3977/4885CDC14A 4435/4885PGR 4271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback